000			01832 a2200517 4500
005			20250514201350.0
264		0	_c20041004
008			200410s 0 0 eng d
022			_a1468-201X
024	7		_a10.1136/hrt.2003.027284 _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, C H
245	0	0	_aBeneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS). _h[electronic resource]
260			_bHeart (British Cardiac Society) _cOct 2004
300			_a1156-61 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAngina Pectoris _xtherapy
650	0	4	_aAngina, Unstable _xtherapy
650	0	4	_aAngioplasty, Balloon, Coronary
650	0	4	_aCardiovascular Diseases _xprevention & control
650	0	4	_aFatty Acids, Monounsaturated _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFluvastatin
650	0	4	_aHumans
650	0	4	_aHypolipidemic Agents _xtherapeutic use
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPostoperative Period
650	0	4	_aProspective Studies
700	1		_ade Feyter, P
700	1		_aSerruys, P W
700	1		_aSaia, F
700	1		_aLemos, P A
700	1		_aGoedhart, D
700	1		_aSoares, P R
700	1		_aUmans, V A W M
700	1		_aCiccone, M
700	1		_aCortellaro, M
773	0		_tHeart (British Cardiac Society) _gvol. 90 _gno. 10 _gp. 1156-61
856	4	0	_uhttps://doi.org/10.1136/hrt.2003.027284 _zAvailable from publisher's website
999			_c15061816 _d15061816